Montana § 37-27-302 Administration Of Prescription Drugs -- When Prohibited -- When Allowed -- Protocols -- Rulemaking

Montana Statutes

§ 37-27-302 — Administration Of Prescription Drugs -- When Prohibited -- When Allowed -- Protocols -- Rulemaking

Montana·Title 37 PROFESSIONS AND OCCUPATIONS·Ch. 27 DIRECT-ENTRY MIDWIFERY·Part 3 Regulation of Practice

37-27-302 . Administration of prescription drugs -- when prohibited -- when allowed -- protocols -- rulemaking.

(1)Except as provided in subsections (2) and (3), a licensed direct-entry midwife may not dispense or administer prescription drugs.

(2)A licensed direct-entry midwife who has successfully completed accredited courses in pharmacology and intravenous therapy approved by the board and has obtained a license endorsement from the board may, during the practice of midwifery, directly obtain and administer the following:

(a)oxygen;

(b)postpartum antihemorrhagic agents, including:

(i)pitocin (intramuscular);

(ii)methylergonovine;

(iii)misoprostol;

(iv)tranexamic acid; and

(v)other postpartum antihemorrhagic drugs allowed by board rule;

(c)injectable local anesthetics for the r

Free access — add to your briefcase to read the full text and ask questions with AI

37-27-302 . Administration of prescription drugs -- when prohibited -- when allowed -- protocols -- rulemaking. (1) Except as provided in subsections (2) and (3), a licensed direct-entry midwife may not dispense or administer prescription drugs.
(2) A licensed direct-entry midwife who has successfully completed accredited courses in pharmacology and intravenous therapy approved by the board and has obtained a license endorsement from the board may, during the practice of midwifery, directly obtain and administer the following:
(a) oxygen;
(b) postpartum antihemorrhagic agents, including:
(i) pitocin (intramuscular);
(ii) methylergonovine;
(iii) misoprostol;
(iv) tranexamic acid; and
(v) other postpartum antihemorrhagic drugs allowed by board rule;
(c) injectable local anesthetics for the repair of up to second-degree lacerations;
(d) antibiotics for group b streptococcus prophylaxis consistent with guidelines of the United States centers for disease control and prevention;
(e) epinephrine administered for anaphylactic shock;
(f) intravenous fluids for fluid replacement and administration of approved medications;
(g) rho(d) immune globulin to prevent maternal immune sensitization to certain fetal blood types;
(h) newborn vitamin K or phytonadione (oral or intramuscular preparations);
(i) in accordance with administrative rules adopted by the department of public health and human services, prophylactic eye agents to newborn infants; and
(j) other medications as prescribed by a medical practitioner or naturopathic physician, including the use of devices as defined in 37-2-101 .
(3) A licensed direct-entry midwife who has successfully completed accredited courses in pharmacology pursuant to subsection (2) may, during the practice of midwifery:
(a) directly obtain terbutaline; and
(b) administer terbutaline to a patient when given a direct order to do so from a licensed physician.
(4) A licensed direct-entry midwife who administers drugs under this section must establish written protocol, including but not limited to:
(a) procurement of prescription drugs, which must be procured from a wholesale drug distributor or pharmacy supplier licensed by the board of pharmacy provided for in 2-15-1733 ;
(b) storage, inventory control, and disposal of prescription drugs; and
(c) use and care of prescription drugs.
(5) The board may adopt rules to implement this section.

Montana § 37-27-302 (Administration Of Prescription Drugs -- When Prohibited -- When Allowed -- Protocols -- Rulemaking) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.